Entrada Therapeutics Inc (TRDA) — Financial Flexibility Index
Entrada Therapeutics Inc (TRDA) has a Financial Flexibility Index of -0.39x as of September 2025. Free cash flow of $-28.14 Million (operating CF $-28.31 Million minus capex $171.00K) represents 0% of total liabilities ($72.18 Million). Also explore how fast is Entrada Therapeutics Inc growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Entrada Therapeutics Inc Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Entrada Therapeutics Inc across 6 annual periods. Check Entrada Therapeutics Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Entrada Therapeutics Inc (2019–2024)
Year-by-year free cash flow to debt coverage for Entrada Therapeutics Inc. For the full company profile including market capitalisation, see how much is Entrada Therapeutics Inc worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.39x | $-38.40 Million | $-41.56 Million | $97.64 Million | ▼ -161.3% |
| 2023 | 0.64x | $145.42 Million | $139.80 Million | $226.83 Million | ▲ +127.9% |
| 2022 | -2.30x | $-90.90 Million | $-93.79 Million | $39.50 Million | ▲ +64.6% |
| 2021 | -6.50x | $-46.28 Million | $-50.86 Million | $7.12 Million | ▼ -2278.4% |
| 2020 | -0.27x | $-23.25 Million | $-25.57 Million | $85.02 Million | ▲ +9.2% |
| 2019 | -0.30x | $-10.17 Million | $-10.80 Million | $33.76 Million | — |